title: NHS generic project: response from the wound care community.
abstract: This series of letters outlines the response from MA Healthcare, key opinion leaders, and industry to the news that the Government is planning to introduce a generic project for wound dressings, limiting products to three main suppliers.
authors.affiliation: Publishing Director, MA Healthcare.
authors.forename: Anthony
authors.initials: A
authors.lastname: Kerr
authors.affiliation: Catalyst Health Economics Consultants, Northwood, Middlesex, UK & Faculty of Life Sciences and Medicine, King's College, London.
authors.forename: Julian F
authors.initials: JF
authors.lastname: Guest
authors.affiliation: Bradford Teaching Hospitals NHS Foundation Trust and University of Bradford.
authors.forename: Peter
authors.initials: P
authors.lastname: Vowden
authors.affiliation: Professor of Tissue Viability, Institute of Health and Society, University of Worcerster, St. John's Campus, Worcester.
authors.forename: Richard
authors.initials: R
authors.lastname: White
authors.affiliation: FCPodMed Head of Podiatry, Solent NHS Trust.
authors.forename: Graham
authors.initials: G
authors.lastname: Bowen
authors.affiliation: Lead Nurse Tissue Viability, Kettering General Hospital NHS Foundation Trust. Deputy Chair EMTVG.
authors.forename: C
authors.initials: C
authors.lastname: Iversen
authors.affiliation: CEO on behalf of Crawford Healthcare LtdQuarterly.
authors.forename: Richard
authors.initials: R
authors.lastname: Anderson
authors.affiliation: Clinical Research Consultant, Hertfordshire.
authors.forename: Keith
authors.initials: K
authors.lastname: Cutting
mesh_terms: D002495:Central Supply, Hospital / Q000458:organization & administration*; D004864:Equipment and Supplies / Q000600:supply & distribution*; D005569:Formularies as Topic; D006801:Humans; D013222:State Medicine / Q000458:organization & administration*; D006113:United Kingdom; D014947:Wounds and Injuries / Q000628:therapy*